Holen Sie sich die Stockscreener-App
37.26
0.56%
-0.21
Handel nachbörslich:
37.26
Schlusskurs vom Vortag:
$37.47
Offen:
$37.59
24-Stunden-Volumen:
3.02M
Relative Volume:
0.47
Marktkapitalisierung:
$18.32B
Einnahmen:
$194.78B
Nettoeinkommen (Verlust:
$-6.68B
KGV:
-2.7353
EPS:
-13.6221
Netto-Cashflow:
$4.32B
1W Leistung:
+2.62%
1M Leistung:
+8.16%
6M Leistung:
+2.25%
1J Leistung:
-40.87%
1-Tages-Spanne:
$37.21
$38.21
1-Wochen-Bereich:
$36.42
$38.21
52-Wochen-Spanne:
$25.07
$64.15
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
37.26 | 18.34B | 194.78B | -6.68B | 4.32B | -13.62 |
UNH
Unitedhealth Group Inc
|
314.19 | 276.23B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
77.62 | 101.67B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
272.60 | 71.52B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
313.35 | 68.43B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
196.21 | 23.07B | 129.66B | 1.20B | 375.00M | 9.8083 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-07-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Herabstufung | UBS | Buy → Neutral |
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
Centene Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo
Centene Corp. stock (US15133V1035): Is Medicaid expansion strength enough to drive steady gains now? - AD HOC NEWS
Centene’s North Carolina Merger Tests Scale Benefits And Undervalued Thesis - Yahoo Finance
Centene Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
More than 500 apartments coming to former Centene campus in University City - MSN
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know - Barchart.com
Centene (CNC) Sees Positive Impact from Medicare Rate Announceme - GuruFocus
2026-04-07 | Bronstein, Gewirtz & Grossman, LLC Encourages Centene Corporation (CNC) Shareholders to Inquire about Securities Investigation | NYSE:CNC | Press Release - Stockhouse
UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments - Benzinga
Centene tumbles on ACA warnings but leads managed care with top buy quant rating - MSN
Centene Corp. stock: Why it's drawing investor attention amid healthcare shifts - AD HOC NEWS
Centene (CNC) Surges 5% Following CMS Medicare Payment Update - GuruFocus
CNC Merges Its North Carolina Divisions to Broaden Presence Across the State - Bitget
Centene names 2 executives to new leadership roles in restructuring - The Business Journals
CNC Combines Its North Carolina Units to Expand Statewide Footprint - TradingView
Centene Announces New Executive Leadership Structure - Finviz
Centene names two group presidents in leadership restructure - Investing.com
Centene Corporation (CNC) stock price, news, quote and history - Yahoo Finance UK
Bronstein, Gewirtz & Grossman, LLC Is Investigating Centene Corporation (CNC) And Encourages Shareholders to Connect - ACCESS Newswire
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Centene Corporation (CNC) And Encourages Shareholders to Connect | NYSE:CNC | Press Release - Stockhouse
Centene Corp. stock outperforms competitors on strong trading day - MSN
CNC PE Ratio & Valuation, Is CNC Overvalued - Intellectia AI
ENGLISH CAPITAL MANAGEMENT LLC's Centene Corp(CNC) Holding History - GuruFocus
St. Vincent Behavioral Health Campus Expands Housing & Health Care for LA with $6M Health Net Investment - Finviz
One North Carolina health plan for 980,000 members, no benefit changes - Stock Titan
Centene's Q1 2026 Earnings: What to Expect - Barchart
UBS Autocallable Notes Linked to Centene (AMUB) — $1,000 Notes, 17.21% Coupon - Stock Titan
Here’s Why Centene Corporation (CNC) Fell in Q4 - Yahoo Finance
JPMorgan Cuts PT on Centene Corporation (CNC) to $41 From $45 – Here’s Why - Insider Monkey
Flournoy Development buys 51 acres from Centene with plans to immediately start project - The Business Journals
Centene Confronts Medicaid Cuts With Multi State Affordable Housing Push - Yahoo Finance
Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period - Finviz
Centene Corp. stock underperforms Friday when compared to competitors - MarketWatch
Carolina Complete Health and Centene Foundation Announce Investment and Groundbreaking of Major Affordable Housing Initiative in Northeast Winston-Salem with McCormack Baron Salazar - ChartMill
Centene : 2026 Proxy Statement & 2025 Annual Report - marketscreener.com
Centene Corp stock faces Medicaid managed care pressures amid management uncertainty - AD HOC NEWS
Centene Corp. stock under pressure from soaring Medicaid costs and sicker member mix in Q1 2026 - AD HOC NEWS
Centene Corporation (CNC) Announces Key Leadership Changes - GuruFocus
Centene Corp (CNC) Shares Gap Down to $31.99 on Mar 25 - GuruFocus
Centene Corp stock faces uncertainty amid Medicaid redeterminations and regulatory shifts in 2026 - AD HOC NEWS
Centene Corp. stock faces pressure from Medicaid redeterminations and rising medical costs - AD HOC NEWS
Health Insurance Providers Stocks Q4 In Review: Centene (NYSE:CNC) Vs Peers - Yahoo Finance
Assenagon Asset Management S.A. Raises Stock Position in Centene Corporation $CNC - MarketBeat
Centene Corp. stock under pressure from Medicaid redeterminations and rising medical costs in Q1 202 - AD HOC NEWS
Centene Corporation Form 8-K Filing Summary for March 18, 2026 – Company Details, Stock Listing, and Compliance Information - Minichart
Centene appoints Theodore Pienkos as chief accounting officer and controller By Investing.com - Investing.com India
Centene appoints Theodore Pienkos as chief accounting officer and controller - Investing.com
Centene Corp stock faces Medicaid redetermination pressures amid 2026 policy shifts - AD HOC NEWS
Theodore Pienkos named Corporate Controller & Chief Accounting Officer at Centene; Kate Casso moves to SVP, Finance Operations and Innovation - TradingView
Centene Corp. stock faces pressure amid Medicaid redeterminations and rising medical costs in Q1 202 - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Centene Corporation (CNC) And Encourages Investors to Connect - ACCESS Newswire
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):